Literature DB >> 16584570

Adult clear cell sarcoma of the kidney: a case report.

Ali R Kural1, Bulent Onal, Hamdi Ozkara, Cansel Cakarir, Inci Ayan, Fulya Y Agaoglu.   

Abstract

BACKGROUND: Clear cell sarcoma of the kidney (CCSK) in adults is extremely rare. Optimal treatment of adult patients with CCSK remains unclear. CASE
PRESENTATION: A 22-year-old man presented with a 2-month history of left flank pain. A color duplex sonography revealed a hypervascular, heterogeneous renal mass. Abdominal and pelvic computerized tomography showed a heterogeneous mass originating from the lower pole of the left kidney and infiltrating to the psoas muscle. Further evaluation including bone scan did not demonstrate any evidence of metastases. A left radical nephrectomy with hilar lymphadenectomy through an intraperitoneal approach with an anterior subcostal incision was performed. The histopathological diagnosis of the mass was a clear cell sarcoma of the kidney. No lymph node metastases were found. Concomitant chemo-radiotherapy was performed. Therapy-related serious side effects were not observed. There was no evidence of local recurrence or metastases during the following twenty-four months after therapy.
CONCLUSION: We believe that the combination therapy is efficacious for preventing the local recurrence and distant metastases. Accurate diagnosis is very important and therapy must also include doxorubicin regardless of the disease stage in adult patients with CCSK.

Entities:  

Mesh:

Year:  2006        PMID: 16584570      PMCID: PMC1513593          DOI: 10.1186/1471-2490-6-11

Source DB:  PubMed          Journal:  BMC Urol        ISSN: 1471-2490            Impact factor:   2.264


  5 in total

Review 1.  Adult clear cell sarcoma of the kidney with atrial tumor thrombus.

Authors:  S B Bhayani; H Liapis; A S Kibel
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

2.  Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center.

Authors:  P Argani; E J Perlman; N E Breslow; N G Browning; D M Green; G J D'Angio; J B Beckwith
Journal:  Am J Surg Pathol       Date:  2000-01       Impact factor: 6.394

Review 3.  Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis.

Authors:  M B Amin; M N de Peralta-Venturina; J Y Ro; A El-Naggar; B Mackay; N Ordonez; A Mani; A Ayala
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

Review 4.  Clear cell sarcoma of the kidney with invasion of the inferior vena cava.

Authors:  D Rosso; G P Ghignone; D Bernardi; A Zitella; G Casetta; A De Zan; A Tizzani
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

5.  [Clear cell sarcoma of the kidney: 3 case reports].

Authors:  Abdellatif Benchekroun; Mohamed Zannoud; Haj Ahmed el Alj; Yassine Nouini; Mohamed Marzouk; Mahomed Faik
Journal:  Prog Urol       Date:  2002-06       Impact factor: 0.915

  5 in total
  5 in total

1.  Clear cell sarcoma of the kidney in children: experience in a developing country.

Authors:  G P Hadley; M H Sheik-Gafoor
Journal:  Pediatr Surg Int       Date:  2010-02-03       Impact factor: 1.827

2.  TLE1 Positive Clear Cell Sarcoma of the Kidney: A Case Report and Review of the Literature.

Authors:  Rana Naous
Journal:  Case Rep Pathol       Date:  2018-10-16

Review 3.  Clear cell sarcoma of the kidney with inferior vena cava thrombus: a case report.

Authors:  Leen Jamel Doya; Khaled Alyousef; Majdy Oukan; Ali Razzok; Basel Shek Alshabab; Tarek AlEid; Rabab Saloum; Hassan Nasser
Journal:  J Med Case Rep       Date:  2022-08-01

4.  Clear cell sarcoma of the kidney misdiagnosed as mesoblastic nephroma: a case report and review of the literature.

Authors:  Samin Alavi; Maliheh Khoddami; Mohammad Kaji Yazdi; Paria Dehghanian; Sadaf Esteghamati
Journal:  Ecancermedicalscience       Date:  2013-04-24

5.  Clear cell sarcoma of the kidney in a 62-year-old patient presenting with generalized pruritus.

Authors:  Yuxi Zhang; Jun Li; Yan Wang
Journal:  BMC Cancer       Date:  2019-11-01       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.